Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019
2021 Standout
Stunting and severe stunting among children under-5 years in Nigeria: A multilevel analysis
2017 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Perinatal management of newborns with haemophilia
2001
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Guideline on the management of haemophilia in the fetus and neonate*
2011
Haemophilia B: Where are we now and what does the future hold?
2017
The risk associated with indwelling catheters in children with haemophilia
2007
Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding
1997
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma
2003 Standout
Antimicrobial peptide defense in Drosophila
1997 StandoutNobel
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation
2006
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
International workshop on immune tolerance induction: consensus recommendations1
2007
Immunoadsorption of factor VIII inhibitors
2004
Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study
2010 StandoutNobel
Clinical applications of C-reactive protein in pediatrics
1997 Standout
Inflammatory response to cardiopulmonary bypass
1993 Standout
The molecular basis of blood coagulation
1988 Standout
Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations
2009
Prevention of stroke: a strategic global imperative
2016
Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience
2007
Consensus recommendations for use of central venous access devices in haemophilia
2004
State of the art in hair analysis for detection of drug and alcohol abuse
2006 Standout
Safety of factor VIII inhibitor bypass activity (FEIBA®): 10‐year compilation of thrombotic adverse events
2002
Safety and efficacy of a plasma‐derived monoclonal purified factor VIII concentrate during 10 years of follow‐up
2007
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
1994 Standout
Home management of haemophilia
2004
Application of acute phase protein measurements in veterinary clinical chemistry
2004 Standout
Central venous access devices in haemophilia
2004
A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura
2007
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Impact of Hemorrhage on Trauma Outcome: An Overview of Epidemiology, Clinical Presentations, and Therapeutic Considerations
2006 Standout
Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individuals
1997
Factor VIIa for Correction of Traumatic Coagulopathy
2004
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Haemophilias A and B
2003
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008)
2010
Kaposi's Sarcoma
2000 Standout
Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin
1991
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high‐titre inhibitors
2007
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
A3 Domain Is Essential for Interaction of von Willebrand Factor with Collagen Type III
1996
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Coordinate accumulation of the mRNAs for the alpha, beta, and gamma chains of rat fibrinogen following defibrination.
1982
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
2012
Interleukin-6 and the acute phase response
1990 Standout
Relationship between Levels of Indinavir in Hair and Virologic Response to Highly Active Antiretroviral Therapy
2002
The Effect of DDAVP Infusion on Thrombin Generation in Platelet-rich Plasma of von Willebrand Type 1 and in Mild Haemophilia A Patients
2000
Disorganization of Cultured Vascular Endothelial Cell Monolayers by Fibrinogen Fragment D
1985 Science
Global stroke statistics
2016 Standout
Insect immunity: developmental and inducible activity of the Drosophila diptericin promoter.
1992 StandoutNobel
Proteolysis of von Willebrand Factor and Shear Stress–Induced Platelet Aggregation in Patients With Aortic Valve Stenosis
2000
Addressing non-communicable diseases in Malaysia: an integrative process of systems and community
2014
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Localization of binding sites within human von Willebrand factor for monomeric type III collagen
1986
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
1982 Standout
Stroke Risk Prediction with Machine Learning Techniques
2022 Standout
Human beta-fibrinogen gene expression. Upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation.
1990
Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III.
1987
Guidelines for the management of hemophilia
2012 Standout
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout
Works of C. M. Kessler being referenced
The use of the Port‐A‐Cath in children with haemophilia — a review
1998
Treatment of von Willebrand disease
1998
The molecular basis of haemophilia B
1998
B‐domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma‐derived factor VIII concentrate: a randomized, three‐way crossover study
2005
Haemophilia treatment protocols around the world: towards a consensus
1998
Resistance to HIV protease inhibitors
1998
Clinical picture and treatment strategies in factor VII deficiency
1998
Safety, efficacy and lessons from continuous infusion with rFVIIa
1998
Stimulation of fibrinogen synthesis: a possible functional role of fibrinogen degradation products
1980
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared with Photochemical Treatment (INTERCEPT Plasma).
2004
Prevention ‒ a cost-effective way to fight the non-communicable disease epidemic
2011
Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups
1995
Collagen-factor VIII/von Willebrand factor protein interaction
1984
Evidence‐based guidelines support integrated disease management as the optimal model of haemophilia care
2016
PSY5 THE USEFULNESS OF REGISTRY DATA FOR UNDERSTANDING TREATMENT PRACTICES AND CLINICAL OUTCOMES IN HEMOPHILIA: THE EXPERIENCE OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY (2004–2008)
2009
A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin
1995